AMLX PEER ANALYSIS

Amylyx Pharmaceuticals Inc — metric-by-metric comparison with peers and the industry median

AMLXAmylyx Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

AMLXIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	AMLX	BHC	ROVI	ECILC	GENIL	HLN	Ind. Median
P/E	—	—	22.08●	—	46.82	31.28	21.37
P/B	7.39	-0.88●	4.32	0.80	3.47	1.98	1.82
EV/EBITDA	—	4.05●	14.64	33.84	14.07	19.15	12.26
P/S	—	0.21●	3.93	5.03	1.86	3.94	2.09

Financial Health
Metric	AMLX	BHC	ROVI	ECILC	GENIL	HLN	Ind. Median
Current Ratio	17.85●	1.32	3.66	1.73	1.33	0.92	2.22
Debt/Equity	2.1%	-1,010.0%●	17.0%	5.9%	41.0%	52.3%	46.3%
NetDebt/EBITDA	1.86	3.71	0.09	-0.10●	1.10	3.50	1.24

Profitability
Metric	AMLX	BHC	ROVI	ECILC	GENIL	HLN	Ind. Median
Net Margin	—	-13.5%	17.8%●	-3.6%	4.0%	12.6%	4.0%
ROE	-63.3%	—	20.9%●	-0.6%	8.7%	6.3%	6.4%
ROA	-58.5%	-4.7%	15.1%●	-0.5%	4.8%	3.2%	3.4%
EBITDA Margin	—	60.0%●	27.0%	14.8%	14.3%	25.2%	18.2%

Growth + Dividend
Metric	AMLX	BHC	ROVI	ECILC	GENIL	HLN	Ind. Median
Rev. Growth	—	-9.9%	-3.4%	-2.3%	16.3%●	-26.7%	7.5%
NI Growth	—	—	-5.9%	—	146.6%●	-14.2%	5.0%
Div. Yield	—	0.0%	1.6%	2.6%●	0.0%	2.0%	2.0%
Payout	—	0.0%	36.3%	-365.1%	0.0%	40.0%	0.8%

Valuation
Metric	AMLX	ANIP	PBH	BCRX	HROW	PRGO	Ind. Median
P/E	—	20.67	12.38●	—	—	—	21.37
P/B	7.39	3.30	1.25	-4.30●	55.43	0.61	1.82
EV/EBITDA	—	7.97●	10.08	—	57.12	—	12.26
P/S	—	2.01	2.16	2.69	5.92	0.37●	2.09

Financial Health
Metric	AMLX	ANIP	PBH	BCRX	HROW	PRGO	Ind. Median
Current Ratio	17.85●	3.12	3.57	1.91	2.48	2.72	2.22
Debt/Equity	2.1%	58.3%	55.4%	-154.9%●	1,047.4%	152.3%	46.3%
NetDebt/EBITDA	1.86	0.07	2.96	-1.66	6.55	-2.78●	1.24

Profitability
Metric	AMLX	ANIP	PBH	BCRX	HROW	PRGO	Ind. Median
Net Margin	—	9.7%	17.5%●	-51.7%	-5.6%	-43.5%	4.0%
ROE	-63.3%	17.8%●	10.2%	—	-35.1%	-53.0%	6.4%
ROA	-58.5%	6.6%●	5.5%	-96.9%	-3.8%	-20.5%	3.4%
EBITDA Margin	—	25.4%	30.4%●	-42.1%	11.7%	-29.7%	18.2%

Growth + Dividend
Metric	AMLX	ANIP	PBH	BCRX	HROW	PRGO	Ind. Median
Rev. Growth	—	37.0%	-4.3%	75.9%●	26.2%	-3.6%	7.5%
NI Growth	—	—	-11.3%	—	—	—	5.0%
Div. Yield	—	0.0%	—	—	—	11.3%●	2.0%
Payout	—	0.8%	—	—	—	-8.7%	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on AMLX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.